Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Plasma cell leukemia: our experience in 4 cases].

F Manso1, J L Bello, J Feliu

  • 1Servicio de Hematología, Hospital La Paz, Madrid.

Revista Clinica Espanola
|November 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Range Transverse-Momentum Correlations and Radial Flow in Pb-Pb Collisions at the LHC.

Physical review letters·2026
Same author

Search for Quasiparticle Scattering in the Quark-Gluon Plasma with Jet Splittings in pp and Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2025
Same author

First Measurement of A=4 Hypernuclei and Antihypernuclei at the LHC.

Physical review letters·2025
Same author

Probing Strangeness Hadronization with Event-by-Event Production of Multistrange Hadrons.

Physical review letters·2025
Same author

Measurements of Chemical Potentials in Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2024
Same author

Observation of Medium-Induced Yield Enhancement and Acoplanarity Broadening of Low-p_{T} Jets from Measurements in pp and Central Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2024

This study examines plasma cell leukemia (PCL) in multiple myeloma patients. PCL cases showed limited response to chemotherapy and poor survival rates, highlighting treatment challenges.

Area of Science:

  • Hematology
  • Oncology

Background:

  • Plasma cell leukemia (PCL) is a rare and aggressive hematologic malignancy.
  • Understanding PCL's clinical presentation and treatment response is crucial for improving patient outcomes.

Observation:

  • This study analyzed four PCL cases among 152 multiple myeloma patients diagnosed between 1969 and 1988.
  • Three PCL cases were primary, and one was secondary.
  • Observed lower incidences of lymphadenopathy and splenomegaly compared to previous reports.

Findings:

  • The incidence of serum M band in PCL was comparable to multiple myeloma.
  • Only one of four patients achieved a partial response (PR) lasting two months with combination chemotherapy.
  • The mean survival duration for these PCL patients was under eight months.

Related Experiment Videos

Implications:

  • The findings suggest limited efficacy of current combination chemotherapy for PCL.
  • Further research into novel therapeutic strategies for plasma cell leukemia is warranted.
  • Early diagnosis and aggressive management are critical for improving prognosis in PCL.